Follow Us:
Saturday, February 29, 2020

Dr Reddy's Laboratories


Dr Reddy's Laboratories posts Q3 loss at Rs 570 crore

January 27, 2020 12:54 pm

The consolidated revenues of the company in the October-December period increased to Rs 4,383.8 crore, over Rs 3,850 crore in the year-ago period, Dr Reddy's Laboratories said in a filing to BSE.

Chinese strategy: Dr Reddy's outsources part manufacturing to local parties

November 21, 2019 4:31 pm

The products are manufactured either in the plant owned by KRRP in China, or partners in China, or in India by Dr. Reddy's

Dr Reddy’s Laboratories faces class action suit

August 29, 2017 1:44 am

“The lawsuit alleges the company made materially false and/or misleading statements or omissions in connection with its corporate quality system and specifically in connection with a warning letter from the US Food and Drug Administration dated November 6, 2015, and a letter from the Regierung von Oberbayern in Germany dated August 10, 2017.."

US court asks DRL to halt sale of ‘Purple Pills’

November 11, 2015 12:57 am

The order has been passed pending further hearing or trial.

Dr Reddy’s, IPCA Labs products come under Canada govt scanner

December 25, 2014 11:46 am

IPCA also got Form 483 in August with six serious deviations for its Madhya Pradesh facility.

Dr Reddy's Lab, Ranbaxy, Glenmark shares hit by worries about Russia, Ukraine sales

March 04, 2014 10:52 am

Dr Reddys Laboratories has the highest exposure to Russia and former Soviet republics.

BSE Sensex jumps by 115 pts,Reliance Industries,Infosys shares gain

November 28, 2013 4:07 pm

BSE Sensex gained 0.71 pct,while broader NSE Nifty index ended higher 0.81 pct.

PM Manmohan Singh pep-talk lifts Sensex by 219 pts to over two-week high,TCS shares hit all-time high

August 30, 2013 3:55 pm

Today is the highest close for Sensex since August 14 (19,367.59).

Dr Reddy’s net up 7% at Rs 361 cr

July 31, 2013 2:35 am

Dr Reddy’s Laboratories today said its net profit rose by over seven per cent to Rs 361 crore for the quarter ended June 30,primarily driven by North American revenues

Dr Reddys Laboratories sued for 'infringement' of thyroid injection patent

June 19, 2013 12:38 pm

US Drug maker requested the court to pass an order to restrain DRL from commercially manufacturing.